U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H13NO2
Molecular Weight 155.1943
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BEMEGRIDE

SMILES

CCC1(C)CC(=O)NC(=O)C1

InChI

InChIKey=ORRZGUBHBVWWOP-UHFFFAOYSA-N
InChI=1S/C8H13NO2/c1-3-8(2)4-6(10)9-7(11)5-8/h3-5H2,1-2H3,(H,9,10,11)

HIDE SMILES / InChI

Molecular Formula C8H13NO2
Molecular Weight 155.1943
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/mesh/68001534 and http://www.ncbi.nlm.nih.gov/pubmed/13489272

Bemegride is a CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose. Bemegride is an antidote for barbiturate poisoning. Bemegride has being shown to have an antagonistic action on the GABAA receptor.

Originator

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions
Doses

Doses

DosePopulationAdverse events​
14 g 1 times / 4 min multiple, intravenous (total)
Highest studied dose
Dose: 14 g, 1 times / 4 min
Route: intravenous
Route: multiple
Dose: 14 g, 1 times / 4 min
Co-administed with::
amiphenazole, i.v(4.2 g, total for 4 days)
Sources: Page: p.758
unhealthy, 58
n = 1
Health Status: unhealthy
Condition: Barbiturate poisoning
Age Group: 58
Sex: F
Population Size: 1
Sources: Page: p.758
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats.
1980 May 12
[Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)].
1980 Sep
Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d. 5th communication: anticonvulsant effects in mice.
1994 Jun
[Changes in energy metabolism in the brain of bemegride-kindled rabbits].
2002
Patents

Sample Use Guides

For the treatment of barbiturate poisoning - 10 ml (50 mg) of bemegride, being injected every three to five minutes
Route of Administration: Intravenous
In Vitro Use Guide
Bemegride (200 uM) together with phenobarbitone (500 uM) reduced the increase in the amplitude of the GABA currents in murine spinal neurones.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:06:14 GMT 2023
Edited
by admin
on Fri Dec 15 15:06:14 GMT 2023
Record UNII
57DQA39DO2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BEMEGRIDE
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
bemegride [INN]
Common Name English
BEMEGRIDE [MART.]
Common Name English
Bemegride [WHO-DD]
Common Name English
MEGIMIDE
Brand Name English
BEMEGRIDE [JAN]
Common Name English
3-ETHYL-3-METHYLGLUTARIMIDE
Systematic Name English
BEMEGRIDE [MI]
Common Name English
MEGIBAL
Brand Name English
NSC-58187
Code English
Classification Tree Code System Code
WHO-ATC R07AB05
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
WHO-VATC QR07AB05
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
NCI_THESAURUS C47795
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID0045250
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
NCI_THESAURUS
C76617
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-588-0
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
PUBCHEM
2310
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
EVMPD
SUB05691MIG
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
NSC
58187
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
DRUG CENTRAL
3013
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
SMS_ID
100000086119
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
CAS
64-65-3
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
INN
511
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
FDA UNII
57DQA39DO2
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
MERCK INDEX
m2299
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY Merck Index
MESH
D001534
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
WIKIPEDIA
Bemegride
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
ChEMBL
CHEMBL1214192
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
DRUG BANK
DB13740
Created by admin on Fri Dec 15 15:06:14 GMT 2023 , Edited by admin on Fri Dec 15 15:06:14 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY